Comparison of WPAI-GH and SF-36v2 scores between normal and severe groups classified by dysmenorrhea score.

<p>Comparison of WPAI-GH and SF-36v2 scores between normal and severe groups classified by dysmenorrhea score.</p>

Gorde:

Xehetasun bibliografikoak
Egile nagusia:	Maika Nariai (22676447) (author)
Beste egile batzuk:	Osamu Wada-Hiraike (162623) (author), Eri Maeda (536672) (author), Masayo Matsuzaki (18630699) (author), Mayuyo Mori-Uchino (6704801) (author), Maho Furukawa (22676450) (author), Yuki Enomoto (4955968) (author), Hiromi Ga (22676453) (author), Risa Takai (22676456) (author), Miyuki Harada (5916098) (author), Yutaka Osuga (456513) (author), Yasushi Hirota (120700) (author)
Argitaratua:	2025
Gaiak:	Microbiology Cell Biology Genetics Neuroscience Biotechnology Immunology Developmental Biology Science Policy Infectious Diseases treatment eligibility may potentially valid criterion 7 %) participants overall work impairment assess work productivity dysmenorrhea significantly affects 2064 women completed activity impairment questionnaire multiple regression analysis 36v2 health survey reduced work productivity dysmenorrhea score questionnaire severe dysmenorrhea group work productivity activity impairment dysmenorrhea score severe group reduced physical japanese women dysmenorrhea remained 555 women xlink "> severe groups sectional study scale cross menstrual pain medication use lunaluna ). impaired absenteeism general health daily activities confounding factors conducted using based self based cross &# 8805
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak